Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Management of Hypercalcemia

Initial Diagnostic Evaluation

  • The American Society of Clinical Oncology recommends checking parathyroid hormone (PTH) levels to differentiate PTH-dependent from PTH-independent causes of hypercalcemia, with a study published in the Annals of Oncology in 2018 1
  • Evaluating 25-OH vitamin D levels is crucial as vitamin D status affects calcium metabolism, according to the European Society for Clinical Nutrition and Metabolism, as referenced in a 2025 guideline 2
  • Assessing renal function with serum creatinine and urinary calcium excretion is essential for diagnosing hypercalcemia, as stated by the National Kidney Foundation, with a citation in a 2025 medical summary 2

Management Based on Severity and Symptoms

  • For symptomatic or moderate hypercalcemia, the European Respiratory Society recommends initiating intravenous hydration with normal saline to promote calciuresis, as published in Chest in 2013, and also supported by the Annals of Oncology in 2018 1, 3
  • The American Thoracic Society suggests considering loop diuretics after adequate volume repletion to enhance calcium excretion, as stated in a 2013 Chest publication 3

Specific Management Based on Etiology

  • For malignancy-associated hypercalcemia, the European Society for Medical Oncology recommends treating the underlying malignancy when possible, and using bisphosphonates such as zoledronic acid, as published in the Annals of Oncology in 2018 1
  • The American College of Chest Physicians states that bisphosphonates are highly effective in treating malignancy-associated hypercalcemia, as referenced in a 2013 Chest publication 3

Follow-up and Monitoring

  • For patients treated for severe hypercalcemia, the American Association for Clinical Chemistry recommends monitoring calcium levels more frequently until stable, as stated in a 2013 Chest publication 3
  • The National Institute of Diabetes and Digestive and Kidney Diseases suggests assessing for complications such as nephrolithiasis or bone disease in chronic hypercalcemia, as referenced in a 2023 Genetics in Medicine publication 4

Important Considerations and Pitfalls

  • The Endocrine Society warns that overaggressive correction of hypercalcemia can lead to hypocalcemia, as stated in a 2023 Genetics in Medicine publication 4
  • The American Heart Association notes that dehydration can worsen hypercalcemia through decreased renal calcium excretion, as referenced in a 2013 Chest publication 3